Back to search

Article

High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency

2024-12-17

Abstract excerpt

Neurofibromatosis type 1 (NF1)-associated high-grade gliomas (HGGs) harboring ATRX mutations exhibit an aggressive clinical phenotype, driven by heightened genomic instability and metabolic reprogramming. Existing therapies, including chemotherapy and radiotherapy, are limited by resistance mechanisms and formation of secondary malignancy, underscoring the need for novel therapeutic strategies. Here, we report the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b8078d0-5d58-5bd0-bb1f-9f98abc437e0
DOI
10.1101/2024.12.14.628525
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX DeficiencyDOI 10.1101/2024.12.14.628525
Select a neighboring publication to make it the new centre.